These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2960644)

  • 1. The effects of topical foscarnet in a new model of herpes simplex skin infection.
    van Genderen J; Wolthuis OL; Ariens AT; Ericson AC; Datema R
    J Antimicrob Chemother; 1987 Oct; 20(4):547-56. PubMed ID: 2960644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
    Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
    J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
    Ulbricht A; Färber I; Wutzler P
    Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.
    Poryo A; Wigand R
    Med Microbiol Immunol; 1984; 173(4):219-24. PubMed ID: 6096685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
    Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J
    Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): double blind, placebo controlled, multicentre study.
    Barton SE; Munday PE; Kinghorn GR; van der Meijden WI; Stolz E; Notowicz A; Rashid S; Schuller JL; Essex-Cater AJ; Kuijpers MH
    Genitourin Med; 1986 Aug; 62(4):247-50. PubMed ID: 2942457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous herpes simplex virus infections.
    Arbesfeld DM; Thomas I
    Am Fam Physician; 1991 May; 43(5):1655-64. PubMed ID: 1826983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Ayisi NK; Gupta SV; Babiuk LA
    Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
    Alenius S
    Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
    Hardy WD
    Am J Med; 1992 Feb; 92(2A):30S-35S. PubMed ID: 1531285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
    Ahlmén J; Wijnween AC; Brynger H; Lycke E
    Scand J Urol Nephrol Suppl; 1985; 92():41-4. PubMed ID: 3008316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
    Spruance SL; Freeman DJ; Sheth NV
    Antimicrob Agents Chemother; 1986 Jul; 30(1):196-8. PubMed ID: 2944480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.
    Stellbrink HJ; Albrecht H; Löning T; Greten H
    Klin Wochenschr; 1991 Apr; 69(6):274-8. PubMed ID: 1828096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foscarnet (phosphonoformate sodium) in the treatment of recurrent male genital herpes.
    Lim KB; Doraisingham S; Thirumoorthy T; Lee CT; Ling AE; Tan T
    Ann Acad Med Singap; 1986 Oct; 15(4):617-22. PubMed ID: 2952046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
    Lawee D; Rosenthal D; Aoki FY; Portnoy J
    CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment of recurrent genital herpes infections with foscarnet.
    Wallin J; Lernestedt JO; Ogenstad S; Lycke E
    Scand J Infect Dis; 1985; 17(2):165-72. PubMed ID: 3161176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model.
    Awan AR; Harmenberg J; Flink O; Field HJ
    Antivir Chem Chemother; 1998 Jan; 9(1):19-24. PubMed ID: 9875373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.